Garvan's Prof Vanessa Hayes discusses her work matching the right prostate cancer treatment to the right patient. Using a 'treatment bucket' approach, a lot of unnecessary or invasive treatments may be avoided.
3 Minute Thesis: Illuminating Prostate Cancer treatment decisions
Anton Kalsbeek from the Genomics and Epigenetics Division, Garvan Institute of Medical Research presenting "Illuminating Prostate Cancer treatment decisions" at the St Vincent’s Precinct 3 Minute Thesis
Professor Vanessa Hayes - Petre Foundation Chair of Prostate Cancer
Professor Vanessa Hayes assumed the inaugural Petre Foundation Chair of Prostate Cancer in January 2014. She heads a Human Comparative and Prostate Cancer Genomics lab at Garvan. Vanessa generated the first complete personalised human DNA sequences (human genomes) for Africa, namely South African and Nobel Peace Laureate Archbishop Desmond Tutu and !Gubi, a Kalahari Bushman from Namibia.
Mapping the genome of prostate cancer uncovers a new world of DNA rearrangements
Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens through which to view prostate cancer – and could one day be used to help characterise an individual’s prostate tumour.
Enhancing prostate cancer prognosis at the micro level
It is now widely acknowledged that ‘non-coding’ genes known as microRNAs play a big role in cancer, through their mechanical regulation of other genes. In a three-year study, Garvan researchers have identified one microRNA, in particular, that is strongly associated with prostate cancer prognosis.
Inaugural grant funds simultaneous breast and prostate cancer research
The Movember Foundation and National Breast Cancer Foundation (NBCF) have awarded the inaugural ‘Breast & Prostate Cancer Linkage Grant’ to an innovative, Australia-led international research project including Garvan researchers.
How Garvan tall poppy searches for prostate cancer gene
Dr Vanessa Hayes, head of the Cancer Genetics Group at the Garvan Institute of Medical Research, has received a prestigious New South Wales Young Tall Poppy Science Award in recognition of her research in prostate cancer.
Study shows that prostate cancer increases the risk of bone fracture
As unlikely as it sounds, scientists at Garvan have shown that there is a link between prostate cancer and a higher risk of bone fracture. Their study suggests that men with prostate cancer face a 50% higher risk of fracture, which increases to nearly 100% if they are receiving androgen deprivation therapy for their prostate cancer.